  (a) Drug-free workplace requirement
    (1) Persons other than individuals
       No person, other than an individual, shall receive a grant from any Federal agency unless such person has certified to the granting agency that it will provide a drug-free workplace by–
      (A) publishing a statement notifying employees that the unlawful manufacture, distribution, dispensation, possession, or use of a controlled substance is prohibited in the grantee“s workplace and specifying the actions that will be taken against employees for violations of such prohibition;
      (B) establishing a drug-free awareness program to inform employees about–
        (i) the dangers of drug abuse in the workplace;
        (ii) the grantee“s policy of maintaining a drug-free workplace;
        (iii) any available drug counseling, rehabilitation, and employee assistance programs; and
        (iv) the penalties that may be imposed upon employees for drug abuse violations;
      (C) making it a requirement that each employee to be engaged in the performance of such grant be given a copy of the statement required by subparagraph (A);
      (D) notifying the employee in the statement required by subparagraph (A), that as a condition of employment in such grant, the employee will–
        (i) abide by the terms of the statement; and
        (ii) notify the employer of any criminal drug statute conviction for a violation occurring in the workplace no later than 5 days after such conviction;
      (E) notifying the granting agency within 10 days after receiving notice of a conviction under subparagraph (D)(ii) from an employee or otherwise receiving actual notice of such conviction;
      (F) imposing a sanction on, or requiring the satisfactory participation in a drug abuse assistance or rehabilitation program by, any employee who is so convicted, as required by section 703 of this title; and
      (G) making a good faith effort to continue to maintain a drug-free workplace through implementation of subparagraphs (A), (B), (C), (D), (E), and (F).
    (2) Individuals
       No Federal agency shall make a grant to any individual unless such individual certifies to the agency as a condition of such grant that the individual will not engage in the unlawful manufacture, distribution, dispensation, possession, or use of a controlled substance in conducting any activity with such grant.
  (b) Suspension, termination, or debarment of grantee
    (1) Grounds for suspension, termination, or debarment
       Each grant awarded by a Federal agency shall be subject to suspension of payments under the grant or termination of the grant, or both, and the grantee thereunder shall be subject to suspension or debarment, in accordance with the requirements of this section if the agency head of the granting agency or his official designee determines, in writing, that–
      (A) the grantee has made a false certification under subsection (a) of this section;
      (B) the grantee violates such certification by failing to carry out the requirements of subparagraph (A), (B), (C), (D), (E), (F), or (G) of subsection (a)(1) of this section; or
      (C) such a number of employees of such grantee have been convicted of violations of criminal drug statutes for violations occurring in the workplace as to indicate that the grantee has failed to make a good faith effort to provide a drug-free workplace as required by subsection (a)(1) of this section.
    (2) Conduct of suspension, termination, and debarment proceedings
       A suspension of payments, termination, or suspension or debarment proceeding subject to this subsection shall be conducted in accordance with applicable law, including Executive Order 12549 or any superseding Executive order and any regulations promulgated to implement such law or Executive order.
    (3) Effect of debarment
       Upon issuance of any final decision under this subsection requiring debarment of a grantee, such grantee shall be ineligible for award of any grant from any Federal agency and for participation in any future grant from any Federal agency for a period specified in the decision, not to exceed 5 years.
